Verily Advisory Board Series: Kathy Giusti on driving change for better health

Kathy Giusti founded the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC) after she was diagnosed with multiple myeloma, a form of blood cancer, in 1998. Twenty years later, Kathy is in complete remission.

A former business executive, Kathy has become a leader in the field of precision medicine for drug development. She is the faculty co-chair of the HBS Kraft Precision Medicine Accelerator and sits on Verily’s Advisory Board in addition to advising Project Baseline.

Verily’s Scarlet Shore, Product Lead for Project Baseline, sat down with Kathy to learn more about her perspective on precision medicine, data sharing, and how to drive innovation in the field of clinical research and care.

Read More